Catalyst Wire Dossier Catalyst Wire Dossier

Hypertonic saline 3% nebulized solution

Hypertonic saline 3%
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hypertonic saline 3% nebulized solution, covering 2017-03-15 to 2017-03-15. Get the full timeline:

Most recent: Clinical Trial Update: Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants [Phase 4]

See pricing